Useful Links
FDA Watch: Lab Industry Objects to Agency’s New LDT Proposal
From – Laboratory Industry Report
On Aug. 3, the Food and Drug Administration heated the long simmering controversy over FDA regulation of laboratory developed tests (LDTs) to full boil by submitting…
G2 Blog
The Safety Interpretation
By Dan Scungio, MT (ASCP), SLS, CQA (ASQ) bio
When hospitals were placed on OSHA’s list of “high-risk” workplaces, no one had to ask why. OSHA adjusts that list based on the number of injuries that occur on the job…
OIG Monthly Work Plan Review: August 2018
From – G2 Compliance Advisor
Of the 12 new Work Plan items, four have direct implications for labs and billing of lab tests…
Hidden Blood in Stool May Indicate Higher All-Cause Death Risk
From – Diagnostic Testing & Emerging Technologies
“Invisible” blood in stool may predict death from a wide range of causes, not just colorectal cancer, according to a study published July 16 in…
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
From – Laboratory Industry Report
Forget the lazy days of summer–lab companies have been moving forward with deals. Here’s a look at key activity from…
HBA1c Blood Test May ID Gestational Diabetes Risk in First Trimester
From – Diagnostic Testing & Emerging Technologies
First trimester HbA1c may aid in early identification of at women at risk of gestational diabetes (GD), according to a study published in Scientific Reports. Such early screening could…